NCT07182981 Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
| NCT ID | NCT07182981 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Systemic Sclerosis (SSc) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-04 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-08-04 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with scleroderma comprehensively and to evaluate them on a biopsychosocial basis to support their disease management. The aim was to assess the biopsychosocial characteristics of both children and adults diagnosed with scleroderma and to examine their chewing and swallowing performance. Additionally, this study aims to identify effective scales that can be used in future research to assess chewing and swallowing in individuals diagnosed with scleroderma.
Eligibility Criteria
For a child diagnosed with scleroderma: Inclusion Criteria: * Cases diagnosed with scleroderma, * Cases aged 7-18 years will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Cases that are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study For adults diagnosed with scleroderma: Inclusion Criteria: * Individuals diagnosed with scleroderma, * Individuals over the age of 18 will be included. Exclusion Criteria: * Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies * Individuals who are not willing to participate in the study will be excluded. * Having participated in a regular exercise program for the past 3 months * Individuals who are not willing to participate in the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07182981 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, studying Systemic Sclerosis (SSc). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07182981 currently recruiting?
Yes, NCT07182981 is actively recruiting participants. Contact the research team at orkuntf@gmail.com for enrollment information.
Where is the NCT07182981 trial being conducted?
This trial is being conducted at Çankaya, Turkey (Türkiye).
Who is sponsoring the NCT07182981 clinical trial?
NCT07182981 is sponsored by Hacettepe University. The trial plans to enroll 50 participants.